Serum γ-glutamyl transferase is associated with plasma total homocysteine in Japanese patients with type 2 diabetes

Acta Diabetologica

Volumn 44, Issue 4, 2007, Pages 177-180

  Sakuta, Hidenari ^a,b   Suzuki, Takashi ^a   Ito, Teizo ^a  

^a Self Defense Forces Central Hospital   (Japan)

^b Department of Internal Medicine   (Japan)

Author keywords

glutamyl transferase; Homocysteine; Oxidative stress; Triglyceride; Type 2 diabetes

Indexed keywords

CREATININE; CYANOCOBALAMIN; FOLIC ACID; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; HOMOCYSTEINE;

ADULT; AGE DISTRIBUTION; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD CHEMISTRY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; UNIVARIATE ANALYSIS; VITAMIN BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HOMOCYSTEINE; HUMANS; JAPAN; LIFE STYLE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 36249012588     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-007-0001-z     Document Type: Article

References (31)

1. Wannamethee G, Ebrahim S, Shaper AG (1995) Gammaglutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 142:699-708
2. Brenner H, Rothenbacher D, Arndt V, Schuberth S, Fraisse E, Fliedner TM (1997) Distribution, determinants, and prognostic value of γ-glutamyl transferase for all-cause mortality in a cohort of construction workers from southern Germany. Prev Med 26:305-310
3. Karlson BW, Wiklund O, Hallgren P, Sjolin M, Lindqvist J, Herlitz J (2000) Ten-year mortality amongst patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia. J Intern Med 247:449-456
4. Welch GN, Loscalzo J (1998) Homocysteine and atherosclerosis. N Engl J Med 338:1042-1050
5. Voutilainen S, Morrow JD, Roberts J II, Alfthan G, Alho H, Nyyssonen K, Salonen JT (1999) Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 19:1263-1266
6. Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS (1999) Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia. An effect reversible with vitamin C therapy. Circulation 99:1156-1160
7. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG (1999) Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 100:1161-1168
8. Zhang F, Slungaard A, Vercellotti GM, Iadecola C (1998) Superoxide-dependent cerebrovascular effects of homocysteine. Am J Physiol 274:R1704-R1711
9. Loscalzo J (1996) The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 98:5-7
10. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Paliski W, Witztum JL (1992) Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 339:883-887
11. Salonen JT, Nyyssonen K, Salonen R, Porkkala-Sarataho E, Tuomaine T-P, Diczfalusy U, Bjorkhem I (1997) Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation 95:840-845
12. Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321
13. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Mitsumura T, Kanedea YU, Yorek MA, Beebe D, Oates PJ, Hammes HP, Glardino I, Brownlee M (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790
14. Penckofer S, Schwertz D, Florczak K (2002) Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants. J Cardiovasc Nurs 16:68-85
15. Whitfield JB (2001) Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38:263-355
16. Kugelman A, Choy HA, Liu R, Shi MM, Gozal E, Forman HJ (1994) γ-Glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells. Am J Resp Cell Mol Biol 11:586-592
17. 2-induced injury by 2,3-dimethoxy-1,4-naphthoquinone. Free Radic Biol Med 15:57-67
18. Karp DR, Shimooku K, Lipsky PE (2001) Expression of gamma- glutamyl transpeptidase protects ramos B cells from oxidation- induced cell death. J Biol Chem 27:3798-3804
19. Lee DH, Blomhoff R, Jacobs DR Jr (2004) Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 38:535-539
20. Herrero JI, Quiroga J, Sangro B, Beloqui O, Pardo F, Cienfuegos JA, Ptieto J (2000) Hyperhomocysteinemia in liver transplant recipients: Prevalence and multivariate analysis of predisposing factors. Liver Transplant 6:614-618
21. Sakuta H, Suzuki T, Yasuda H, Ito T (2005) γ-Glutamyl transferase and risk factors for cardiovascular disease. Intern Med 44:538-541
22. Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga C (2001) Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 44:834-838
23. Ceriello A, Quagliaro L, Catone B, Pascon R, Piazzola M, Bais B, Marra G, Tonutti L, Taboga C, Motz E (2002) Role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care 25:1439-1443
24. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H (1999) Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 34:146-154
25. 2α and platelet activation in diabetes mellitus. Effects of improved metabolic control and vitamin E supplementation. Circulation 99:224-229
26. 2 isoprostanes: Direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. Diabetes Care 25:537-541
27. Shipchandler MT, Moore EG (1995) Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem 41:991-994
28. Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJC, Jacobs C, Bouter LM, Heine RJ, Stehouwer CDA (1998) Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 18:133-138
29. Audelin MC, Genest J Jr (2001) Homocysteine and cardiovascular disease in diabetes mellitus. Atherosclerosis 159:497-511
30. Becker A, Kostense PJ, Bos G, Heine RJ, Dekker JM, Nijpels G, Bouter LM, Stehouwer CD (2003) Hyperhomocysteinemia is associated with coronary events in type 2 diabetes. J Intern Med 253:293-300
31. Shukla N, Thompson CS, Angelini GD, Mikhailidis DP, Jeremy JY (2002) Homocysteine enhances impairment of endothelium-dependent relaxation and guanosine cyclic monophosphate formation in aortae from diabetic rabbits. Diabetologia 45:1325-1331